Targeting IL-4 for the Treatment of Atopic Dermatitis

被引：0
|
作者：
Chiricozzi, Andrea [1 ,2 ]
Maurelli, Martina [3 ]
Peris, Ketty [1 ,2 ]
Girolomoni, Giampiero [3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dermatol, Rome, Italy
[3] Univ Verona, Dept Med, Sect Dermatol, Verona, Italy
来源：
IMMUNOTARGETS AND THERAPY | 2020年 / 9卷
关键词：
atopic dermatitis; IL-4; inhibitor; dupilumab; pascolizumab; pitrakinra; TH2; CYTOKINES; STAPHYLOCOCCUS-AUREUS; DERMAL FIBROBLASTS; DENDRITIC CELLS; TRANSGENIC MICE; LESIONAL SKIN; UP-REGULATION; IFN-GAMMA; IN-VITRO; T-CELLS;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Atopic dermatitis (AD) is an immune-mediated inflammatory skin disease characterized by a predominant type 2 immune response. Type 2 immunity is driven by multiple cytokines, including interleukin (IL)-4 and IL-13 that are considered central to AD pathogenesis and key therapeutic targets. The dual inhibition of these two cytokines or the selective inhibition of IL-13 proved elevated efficacy in treating AD, whereas the selective inhibition of IL-4 has been poorly investigated as IL-4 inhibiting agents did not show any advance in clinical development programs. This review describes the pathogenic role of IL-4 in AD and briefly resumes the main features of compounds selectively blocking IL-4.
引用
收藏
页码：151 / 156
页数：6
相关论文
共 50 条
  • [1] New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines
    Renert-Yuval, Yael
    Guttman-Yassky, Emma
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (01) : 28 - 35
  • [2] The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis
    Pappa, Georgia
    Sgouros, Dimitrios
    Theodoropoulos, Konstantinos
    Kanelleas, Antonios
    Bozi, Evangelia
    Gregoriou, Stamatios
    Krasagakis, Konstantinos
    Katoulis, Alexander C.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [3] IL-4 and IL-13 Inhibition in Atopic Dermatitis
    Matsunaga, Matthew C.
    Yamauchi, Paul S.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (08) : 925 - 929
  • [4] IL-4 and IL-13 inhibition in atopic dermatitis, a review
    Matsunaga, Matthew
    Yamauchi, Paul
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB87 - AB87
  • [5] The IL-4, IL-13 and IL-31 pathways in atopic dermatitis
    Dubin, Celina
    Del Duca, Ester
    Guttman-Yassky, Emma
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (08) : 835 - 852
  • [6] IL-4 and sCD23 in children with atopic dermatitis - Reply
    Katamura, K
    Ohshima, Y
    Miura, M
    Mikawa, H
    Mayumi, M
    EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (06) : 521 - 522
  • [7] Atopic Dermatitis: Biologikum inhibits IL-4 and IL-13 Signaling Pathways
    Walter, Monika
    ALLERGO JOURNAL, 2020, 29 (06) : 80 - 80
  • [8] Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis
    Takahiro Tazawa
    Hisashi Sugiura
    Yasuo Sugiura
    Masami Uehara
    Archives of Dermatological Research, 2004, 295 : 459 - 464
  • [9] Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis
    Tazawa, T
    Sugiura, H
    Sugiura, Y
    Uehara, M
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2004, 295 (11) : 459 - 464
  • [10] Identification of IL-4 regulated keratinocyte genes relevant in the pathogenesis of atopic dermatitis
    Bao, L.
    Chan, L. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S3 - S3
12345